Kopra Bio
- Biotech or pharma, therapeutic R&D
Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer using technology developed at UCSF. In the most challenging brain cancer model, our lead candidate, KB-516, improves long-term survival to 90%.
Our mission is to develop innovative therapies for solid tumors leveraging our proprietary vectorized immunotherapy platform, InViTE (In Vivo Tumor Editing). This breakthrough approach enables safe, specific, and durable delivery of therapeutic payloads to solid tumors.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}